SCHEMBL5530486

SCHEMBL5530486

NNc1c(C(=O)O)cccc1-c1ccccc1O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.50
KDM4E B2RXH2 3/20 0.50
HPGD P15428 3/20 0.50
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
HMGB1 P09429 1/20 0.50
CA4 P22748 1/20 0.50
CA6 P23280 1/20 0.50
CA7 P43166 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CA9 Q16790 1/20 0.50
NAPRT Q6XQN6 1/20 0.50
CA14 Q9ULX7 1/20 0.50
G6PD P11413 1/20 0.49
CASP7 P55210 1/20 0.49
CASP6 P55212 1/20 0.49
HNF4A P41235 1/20 0.46
MYC P01106 1/20 0.45
LMNA P02545 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17744801 0.83 MMP2 (0.49) ALDH1A1KDM4ESMN1; SMN2G6PDCASP7
SCHEMBL725315 0.80 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL29876454 0.78 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL1919550 0.78 ALDH1A1 (0.67) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL15060465 0.77 G6PD (0.69) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL29386467 0.77 G6PD (0.69) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL135374 0.77 PLK1 (0.45) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL28429427 0.77 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL8081427 0.77 HNF4A (0.69) ALDH1A1KDM4EHPGDCA12CA1
SCHEMBL8747590 0.76 ALDH1A1 (0.64) ALDH1A1KDM4EHPGDCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119638575-A Method for preparing key intermediate of eltrombopag by one-pot method 浙江国邦药业有限公司 2025-03-18 CN disclosed
CN-116874428-B PNPO inhibitor with multiple myeloma resisting effect, and preparation method and application thereof 南京中医药大学 2025-01-28 CN disclosed
CN-116874428-A PNPO inhibitor with multiple myeloma resisting effect, and preparation method and application thereof 南京中医药大学 2023-10-13 CN disclosed
EP-1805155-A1 THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS, INC. (US) 2007-07-11 EP disclosed
WO-2006047344-A1 THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS AND METHODS LIGAND PHARMACEUTICALS, INC. (US) 2006-05-04 WO disclosed